CDMO Strength CABB operates as a leading contract development and manufacturing organization for starting materials, active ingredients and advanced intermediates, enabling potential sales opportunities in CRO/CDMO partnerships, toll manufacturing, and long-term supply agreements with crop sciences, life sciences and pharma players.

Global Footprint With five production sites across Europe and Asia and around 1,000 employees, CABB offers regional manufacturing capabilities and scalability to support multinational customers seeking diversified manufacturing hubs and risk mitigation in supply chains.

Complex Molecules Specialization in customized, highly complex molecules suggests opportunities to target customers requiring specialized chemistries, advanced intermediates, and tailored process development, where niche expertise can justify premium pricing and long-term partnerships.

Financial Scale Annual sales near half a billion euros indicate a mid-sized, financially stable partner capable of supporting medium- to long-duration programs, with potential for increased project scope through expanded capacity or investment in new capabilities.

Digital Readiness Current tech stack and digital infrastructure (SAP, Linux, Proxmox, web assets) signals baseline process automation and IT maturity, presenting upsell opportunities in data-driven manufacturing, ERP-integrated CDMO workflows, and enhanced collaboration tools for customers.